Association of rs1800471 polymorphism of TGFB1 gene with chronic kidney disease occurrence and progression and hypertension appearance

Archives of Medical Science

Volumn 9, Issue 2, 2013, Pages 230-237

  Nabrdalik, Katarzyna ^a   Gumprecht, Janusz ^a   Adamczyk, Piotr ^a   Górczyńska Kosiorz, Sylwia ^a   Zywiec, Joanna ^a   Grzeszczak, Władyłsaw ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Case control study; Genetic risk factors; Kidney diseases; Very old people

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84876931492     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2013.34418     Document Type: Article

References (38)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the united states. JAMA 2007; 298: 2038-47. (Pubitemid 350074801)
2. Scott GS, John RS, Sudha KI, Barry IF. Familial clustering of chronic kidney disease. Seminars in Dialysis 2007; 20: 229-36.
3. Cargill M, Altshuler D, Ireland J, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22: 231-8. (Pubitemid 29297248)
4. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286-92. (Pubitemid 24333194)
5. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12. (Pubitemid 38020692)
6. Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 2002; 136: 604-15. (Pubitemid 34407045)
7. Nakamura T, Miller D, Ruoslahti E, Border WA. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int 1992; 41: 1213-21.
8. Li B, Khanna A, Sharma V, et al. TGF-b1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 1999; 33: 271-5. (Pubitemid 29065671)
9. Cambien F, Ricard S, Troesch A, et al. Polymorphisms of the transforming growth factor-beta1 gene in relation to myocardial infarction and blood pressure: the Etude Castemoin de l'infarctus du Myocarde (ECTIM) study. Hypertension 1996; 28: 881-7. (Pubitemid 26365534)
10. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8: 93-7. (Pubitemid 29039053)
11. Hu BC, Chu SL, Wang GL, et al. Association between genetic variation in transforming growth factors beta1 and beta3 and renal dysfunction in non-diabetic Chinese. Clin Exp Hypertens 2008; 30: 121-31.
12. Khalil MS, El Nahas AM, Blakemore AI. Transforming growth factor-beta1 SNPS: genetic and phenotypic correlations in progressive kidney insufficiency. Nephron Exp Nephrol 2005; 101: e31-41. (Pubitemid 41208899)
13. Patel A, Scott WR, Lympany PA, et al. The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in type 1 diabetes. Diabet Med 2005; 22: 69-73. (Pubitemid 40188289)
14. Ng DP, Warram JH, Krolewski AS. TGF-beta 1 as a genetic susceptibility locus for advanced diabetic nephropathy in type 1 diabetes mellitus: an investigation of multiple known DNA sequence variants. Am J Kidney Dis 2003; 41: 22-8. (Pubitemid 36043348)
15. McKnight A, Savage D, Patterson C, Sadlier D, Maxwell AP. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy. BMC Medical Genetics 2007; 8: 5.
16. Buraczynska M, Baranowicz-Gaszczyk I, Borowicz E, Ksiazek A. TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. Nephron Physiol 2007; 106: 69-75.
17. Babel N, Gabdrakhmanova L, Hammer MH, et al. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease. J Nephrol 2006; 19: 802-7. (Pubitemid 46415987)
18. Summers AM, Coupes BM, Brennan MF, et al. VEGF-460 genotype plays an important role in progression to chronic kidney disease stage 5. Nephrol Dial Transplant 2005; 20: 2427-32. (Pubitemid 41548867)
19. Wood NAP, Thomson SC, Smith RM, Bidwell JL. Identification of human TGF-[beta]1 signal (leader) sequence polymorphisms by PCR-RFLP. J Immunol Methods 2000; 234: 117-22. (Pubitemid 30084805)
20. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005; 16: 459-66. (Pubitemid 41725142)
21. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-63.
22. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease. Improving global out comes (KDIGO) 2005; 67: 2089-100.
23. Mittal RD, Manchanda PK. Is low-frequency distribution of TGF-beta genotype associated with increased risk for end-stage renal disease? DNA Cell Biol 2007; 26: 172-7. (Pubitemid 46557385)
24. Coll E, Cormand B, Campos B, et al. Association of TGF-beta1 polymorphisms with chronic renal disease. J Nephrol 2004; 17: 794-9. (Pubitemid 41158299)
25. Dell'omo G, Penno G, Pucci L, et al. Lack of association between tgf-{beta}-1 genotypes and microalbuminuria in essential hypertensive men. Nephrol Dial Transplant 2009; 28: 28.
26. Kim Y, Lee C. The gene encoding transforming growth factor {beta}1 confers risk of ischemic stroke and vascular dementia. Stroke 2006; 37: 2843-5. (Pubitemid 44922550)
27. Awad MR, El-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 66: 1014-20. (Pubitemid 28513380)
28. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29->C polymorphism of the transforming growth factor-{beta}1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000; 101: 2783-7. (Pubitemid 30396007)
29. Matsuda T, Yamamoto T, Muraguchi A, Saatcioglu F. Cross-talk between transforming growth factor-beta and estrogen receptor signaling through smad3. J Biol Chem 2001; 276: 42908-14.
30. Jafar TH, Schmid CH, Stark PC, et al. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. Nephrol Dial Transplant 2003; 18: 2047-53.
31. Cattran DC, Reich HN, Beanlands HJ, et al. The impact of sex in primary glomerulonephritis. Nephrol Dial Transplant 2008; 23: 2247-53. (Pubitemid 351957578)
32. Iliescu R, Reckelhoff JF. Sex and the kidney. Hypertension 2008; 51: 1000-1. (Pubitemid 351398954)
33. Locatelli F, Del Vecchio L, Andrulli S, Marai P, Tentori F. The role of underlying nephropathy in the progression of renal disease. Kidney Int Suppl 2000; 75: S49-55. (Pubitemid 30205440)
34. El-Gamel A, Awad MR, Hasleton PS, et al. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. J Heart Lung Transplant 1999; 18: 517-23. (Pubitemid 29291657)
35. Carrieri G, Marzi E, Olivieri F, et al. The G/C915 poly morphism of transforming growth factor beta1 is associated with human longevity: a study in Italian centenarians. Aging Cell 2004; 3: 443-8. (Pubitemid 40246713)
36. Sprangers B, Evenepoel P, Vanrenterghem Y. Late referral of patients with chronic kidney disease: no time to waste. Mayo Clinic Proceedings 2006; 81: 1487-94. (Pubitemid 44685014)
37. Couser W, Riella M. World Kidney Day 2011 - protect your kidneys, save your heart. Arch Med Sci 2011; 7: 1-4.
38. Wilkening S, Chen B, Bermejo JL, Canzian F. Is there still a need for candidate gene approaches in the era of genome-wide association studies? Genomics 2009; 93: 415-9.